Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
EMPFIELD JAMES R.
EVP, Drug Discovery at Xenon Pharmaceuticals. Filing since 15 Aug 2017.
CIK 0001665430
Company
Date
Role
Action
Shares
Amount
Of holding
XENE
Xenon Pharmaceuticals Inc.
12 Aug 2022
EVP, Drug Discovery
Sold, plan not stated
57,743
$2.21M
85.2%
XENE
Xenon Pharmaceuticals Inc.
7 Mar 2022
EVP, Drug Discovery
Sold, plan not stated
32,853
$1.00M
76.7%
XENE
Xenon Pharmaceuticals Inc.
4 Mar 2022
EVP, Drug Discovery
Sold, plan not stated
18,315
$563.92K
64.7%
XENE
Xenon Pharmaceuticals Inc.
15 Aug 2017
SVP, Drug Discovery
Bought
10,000
$24.82K
opened
4 decisions on file.
